Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

Impact of hospital nephrectomy volume on intermediate- to long-term survival in renal cell carcinoma.

Hsu RCJ, Barclay M, Loughran MA, Lyratzopoulos G, Gnanapragasam VJ, Armitage JN.

BJU Int. 2019 Jun 17. doi: 10.1111/bju.14848. [Epub ahead of print]

PMID:
31206987
2.

NP student encounters with obesity bias in clinical practice.

Hauff C, Fruh SM, Graves RJ, Sims BM, Williams SG, Minchew LA, Hall HR, Platt TH, Barclay M.

Nurse Pract. 2019 Jun;44(6):41-46. doi: 10.1097/01.NPR.0000558157.76596.c7.

PMID:
31107807
3.

A ‘telephone first’ approach to demand management in English general practice: a multimethod evaluation.

Newbould J, Ball S, Abel G, Barclay M, Brown T, Corbett J, Doble B, Elliott M, Exley J, Knack A, Martin A, Pitchforth E, Saunders C, Wilson ECF, Winpenny E, Yang M, Roland M.

Southampton (UK): NIHR Journals Library; 2019 May.

4.

The influence of patient case mix on public health area statistics for cancer stage at diagnosis: a cross-sectional study.

Barclay ME, Abel GA, Elliss-Brookes L, Greenberg DC, Lyratzopoulos G.

Eur J Public Health. 2019 Mar 14. pii: ckz024. doi: 10.1093/eurpub/ckz024. [Epub ahead of print]

PMID:
30869123
5.

New Zealand Society of Gastroenterology Guidelines on Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

Khan A, Berahmana AB, Day AS, Barclay ML, Schultz M.

N Z Med J. 2019 Mar 8;132(1491):46-62.

PMID:
30845128
6.

Incidence of second and higher order smoking-related primary cancers following lung cancer: a population-based cohort study.

Barclay ME, Lyratzopoulos G, Walter FM, Jefferies S, Peake MD, Rintoul RC.

Thorax. 2019 May;74(5):466-472. doi: 10.1136/thoraxjnl-2018-212456. Epub 2019 Feb 18.

7.

The role of the dihedral angle and excited cation states in ionization and dissociation of mono-halogenated biphenyls; a combined experimental and theoretical coupled cluster study.

Barclay M, Bjornsson R, Cipriani M, Terfort A, Fairbrother DH, Ingólfsson O.

Phys Chem Chem Phys. 2019 Feb 20;21(8):4556-4567. doi: 10.1039/c8cp07785a.

PMID:
30741276
8.

Improving women's knowledge about prenatal screening in the era of non-invasive prenatal testing for Down syndrome - development and acceptability of a low literacy decision aid.

Smith SK, Cai A, Wong M, Sousa MS, Peate M, Welsh A, Meiser B, Kaur R, Halliday J, Lewis S, Trevena L, Yanes T, Barlow-Stewart K, Barclay M.

BMC Pregnancy Childbirth. 2018 Dec 17;18(1):499. doi: 10.1186/s12884-018-2135-0.

9.

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose.

Stamp LK, Chapman PT, Barclay ML, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2018 Nov 16;20(1):255. doi: 10.1186/s13075-018-1755-0.

10.

On the identity of a U.S. intercepted Conotrachelus Dejean (Coleoptera: Curculionidae) with avocado (Persea americana).

Chamorro ML, Barclay MVL.

Biodivers Data J. 2018 Nov 2;(6):e26362. doi: 10.3897/BDJ.6.e26362. eCollection 2018.

11.

Positive Psychological Constructs and Health Outcomes in Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.

Amonoo HL, Barclay ME, El-Jawahri A, Traeger LN, Lee SJ, Huffman JC.

Biol Blood Marrow Transplant. 2019 Jan;25(1):e5-e16. doi: 10.1016/j.bbmt.2018.09.030. Epub 2018 Oct 8. Review.

PMID:
30308327
12.

Probing Dynamics in Higher-Lying Electronic States with Resonance-Enhanced Femtosecond Stimulated Raman Spectroscopy.

Quincy TJ, Barclay MS, Caricato M, Elles CG.

J Phys Chem A. 2018 Oct 25;122(42):8308-8319. doi: 10.1021/acs.jpca.8b07855. Epub 2018 Oct 10.

PMID:
30256101
13.

Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomised controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Rheumatology (Oxford). 2018 Dec 1;57(12):2183-2189. doi: 10.1093/rheumatology/key237.

PMID:
30107437
14.

Stage-specific incidence trends of melanoma in an English region, 1996-2015: longitudinal analyses of population-based data.

Herbert A, Koo MM, Barclay ME, Greenberg DC, Abel GA, Levell NJ, Lyratzopoulos G.

Melanoma Res. 2018 Aug 13. doi: 10.1097/CMR.0000000000000489. [Epub ahead of print]

PMID:
30106842
15.

The problem with composite indicators.

Barclay M, Dixon-Woods M, Lyratzopoulos G.

BMJ Qual Saf. 2019 Apr;28(4):338-344. doi: 10.1136/bmjqs-2018-007798. Epub 2018 Aug 12.

16.

Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays.

Barclay ML, Karim S, Helms ETJ, Keating PE, Hock B, Stamp LK, Schultz M.

Intern Med J. 2019 Apr;49(4):513-518. doi: 10.1111/imj.14064.

PMID:
30091273
17.

Associations of Observed Performance Monitoring During Preschool With Obsessive-Compulsive Disorder and Anterior Cingulate Cortex Volume Over 12 Years.

Gilbert KE, Barclay ME, Tillman R, Barch DM, Luby JL.

JAMA Psychiatry. 2018 Sep 1;75(9):940-948. doi: 10.1001/jamapsychiatry.2018.1805.

18.

A Pilot Randomized Controlled Double-Blind Trial of High- Versus Low-Dose Weekly Folic Acid in People With Rheumatoid Arthritis Receiving Methotrexate.

Stamp LK, OʼDonnell JL, Frampton C, Drake J, Zhang M, Barclay M, Chapman PT.

J Clin Rheumatol. 2018 Jul 11. doi: 10.1097/RHU.0000000000000848. [Epub ahead of print]

PMID:
30001258
19.

Seronegative enteropathy and malnutrition: a diagnostic challenge.

McCulloch J, Barclay M, Levene A, Fearn R.

BMJ Case Rep. 2018 May 26;2018. pii: bcr-2018-224397. doi: 10.1136/bcr-2018-224397.

PMID:
29804077
20.

Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease.

Roberts RL, Wallace MC, Seinen ML, van Bodegraven AA, Krishnaprasad K, Jones GT, van Rij AM, Baird A, Lawrance IC, Prosser R, Bampton P, Grafton R, Simms LA, Studd C, Bell SJ, Kennedy MA, Halliwell J, Gearry RB, Radford-Smith G, Andrews JM, McHugh PC, Barclay ML.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2606-2612. doi: 10.1093/ibd/izy163.

PMID:
29788244
21.

Time trends in service provision and survival outcomes for patients with renal cancer treated by nephrectomy in England 2000-2010.

Hsu RCJ, Barclay M, Loughran MA, Lyratzopoulos G, Gnanapragasam VJ, Armitage JN.

BJU Int. 2018 Oct;122(4):599-609. doi: 10.1111/bju.14217. Epub 2018 Apr 20.

22.

'It feels like being trapped in an abusive relationship': bullying prevalence and consequences in the New Zealand senior medical workforce: a cross-sectional study.

Chambers CNL, Frampton CMA, McKee M, Barclay M.

BMJ Open. 2018 Mar 19;8(3):e020158. doi: 10.1136/bmjopen-2017-020158.

23.

Taxonomy based on science is necessary for global conservation.

Thomson SA, Pyle RL, Ahyong ST, Alonso-Zarazaga M, Ammirati J, Araya JF, Ascher JS, Audisio TL, Azevedo-Santos VM, Bailly N, Baker WJ, Balke M, Barclay MVL, Barrett RL, Benine RC, Bickerstaff JRM, Bouchard P, Bour R, Bourgoin T, Boyko CB, Breure ASH, Brothers DJ, Byng JW, Campbell D, Ceríaco LMP, Cernák I, Cerretti P, Chang CH, Cho S, Copus JM, Costello MJ, Cseh A, Csuzdi C, Culham A, D'Elía G, d'Udekem d'Acoz C, Daneliya ME, Dekker R, Dickinson EC, Dickinson TA, van Dijk PP, Dijkstra KB, Dima B, Dmitriev DA, Duistermaat L, Dumbacher JP, Eiserhardt WL, Ekrem T, Evenhuis NL, Faille A, Fernández-Triana JL, Fiesler E, Fishbein M, Fordham BG, Freitas AVL, Friol NR, Fritz U, Frøslev T, Funk VA, Gaimari SD, Garbino GST, Garraffoni ARS, Geml J, Gill AC, Gray A, Grazziotin FG, Greenslade P, Gutiérrez EE, Harvey MS, Hazevoet CJ, He K, He X, Helfer S, Helgen KM, van Heteren AH, Hita Garcia F, Holstein N, Horváth MK, Hovenkamp PH, Hwang WS, Hyvönen J, Islam MB, Iverson JB, Ivie MA, Jaafar Z, Jackson MD, Jayat JP, Johnson NF, Kaiser H, Klitgård BB, Knapp DG, Kojima JI, Kõljalg U, Kontschán J, Krell FT, Krisai-Greilhuber I, Kullander S, Latella L, Lattke JE, Lencioni V, Lewis GP, Lhano MG, Lujan NK, Luksenburg JA, Mariaux J, Marinho-Filho J, Marshall CJ, Mate JF, McDonough MM, Michel E, Miranda VFO, Mitroiu MD, Molinari J, Monks S, Moore AJ, Moratelli R, Murányi D, Nakano T, Nikolaeva S, Noyes J, Ohl M, Oleas NH, Orrell T, Páll-Gergely B, Pape T, Papp V, Parenti LR, Patterson D, Pavlinov IY, Pine RH, Poczai P, Prado J, Prathapan D, Rabeler RK, Randall JE, Rheindt FE, Rhodin AGJ, Rodríguez SM, Rogers DC, Roque FO, Rowe KC, Ruedas LA, Salazar-Bravo J, Salvador RB, Sangster G, Sarmiento CE, Schigel DS, Schmidt S, Schueler FW, Segers H, Snow N, Souza-Dias PGB, Stals R, Stenroos S, Stone RD, Sturm CF, Štys P, Teta P, Thomas DC, Timm RM, Tindall BJ, Todd JA, Triebel D, Valdecasas AG, Vizzini A, Vorontsova MS, de Vos JM, Wagner P, Watling L, Weakley A, Welter-Schultes F, Whitmore D, Wilding N, Will K, Williams J, Wilson K, Winston JE, Wüster W, Yanega D, Yeates DK, Zaher H, Zhang G, Zhang ZQ, Zhou HZ.

PLoS Biol. 2018 Mar 14;16(3):e2005075. doi: 10.1371/journal.pbio.2005075. eCollection 2018 Mar. No abstract available.

24.

Late-onset Rise of 6-MMP Metabolites in IBD Patients on Azathioprine or Mercaptopurine.

Munnig-Schmidt E, Zhang M, Mulder CJ, Barclay ML.

Inflamm Bowel Dis. 2018 Mar 19;24(4):892-896. doi: 10.1093/ibd/izx081.

PMID:
29522107
25.

Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).

Friedman AB, Brown SJ, Bampton P, Barclay ML, Chung A, Macrae FA, McKenzie J, Reynolds J, Gibson PR, Hanauer SB, Sparrow MP.

Aliment Pharmacol Ther. 2018 Apr;47(8):1092-1102. doi: 10.1111/apt.14571. Epub 2018 Feb 21.

PMID:
29468701
26.

Combination Immunosuppression in IBD.

Bots S, Gecse K, Barclay M, D'Haens G.

Inflamm Bowel Dis. 2018 Feb 15;24(3):539-545. doi: 10.1093/ibd/izx065. Review.

PMID:
29462391
27.

The effect of manual therapy and neuroplasticity education on chronic low back pain: a randomized clinical trial.

Louw A, Farrell K, Landers M, Barclay M, Goodman E, Gillund J, McCaffrey S, Timmerman L.

J Man Manip Ther. 2017 Dec;25(5):227-234. doi: 10.1080/10669817.2016.1231860. Epub 2016 Sep 22.

28.

Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease.

Barclay ML, Stamp LK.

Aliment Pharmacol Ther. 2018 Feb;47(4):535-536. doi: 10.1111/apt.14465. No abstract available.

PMID:
29341275
29.

The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.

Wright DFB, Dalbeth N, Phipps-Green AJ, Merriman TR, Barclay ML, Drake J, Tan P, Horne A, Stamp LK.

Br J Clin Pharmacol. 2018 May;84(5):937-943. doi: 10.1111/bcp.13516. Epub 2018 Feb 20.

30.

Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.

de Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, Colombel JF, Lopez A, Beaugerie L, Marinaki AM, van Bodegraven AA, Neurath MF.

J Crohns Colitis. 2018 Apr 27;12(5):610-620. doi: 10.1093/ecco-jcc/jjx181. Review.

PMID:
29293971
31.

How to prevent allopurinol hypersensitivity reactions?

Stamp LK, Barclay ML.

Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i35-i41. doi: 10.1093/rheumatology/kex422. Review.

PMID:
29272508
32.

The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Arthritis Res Ther. 2017 Dec 21;19(1):283. doi: 10.1186/s13075-017-1491-x.

33.

Amplified cross-linking efficiency of self-assembled monolayers through targeted dissociative electron attachment for the production of carbon nanomembranes.

Koch S, Kaiser CD, Penner P, Barclay M, Frommeyer L, Emmrich D, Stohmann P, Abu-Husein T, Terfort A, Fairbrother DH, Ingólfsson O, Gölzhäuser A.

Beilstein J Nanotechnol. 2017 Nov 30;8:2562-2571. doi: 10.3762/bjnano.8.256. eCollection 2017.

34.

Comparing postdeposition reactions of electrons and radicals with Pt nanostructures created by focused electron beam induced deposition.

Spencer JA, Barclay M, Gallagher MJ, Winkler R, Unlu I, Wu YC, Plank H, McElwee-White L, Fairbrother DH.

Beilstein J Nanotechnol. 2017 Nov 15;8:2410-2424. doi: 10.3762/bjnano.8.240. eCollection 2017.

35.

Missing data and chance variation in public reporting of cancer stage at diagnosis: Cross-sectional analysis of population-based data in England.

Barclay ME, Lyratzopoulos G, Greenberg DC, Abel GA.

Cancer Epidemiol. 2018 Feb;52:28-42. doi: 10.1016/j.canep.2017.11.005. Epub 2017 Nov 23.

36.

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

Mitrev N, Vande Casteele N, Seow CH, Andrews JM, Connor SJ, Moore GT, Barclay M, Begun J, Bryant R, Chan W, Corte C, Ghaly S, Lemberg DA, Kariyawasam V, Lewindon P, Martin J, Mountifield R, Radford-Smith G, Slobodian P, Sparrow M, Toong C, van Langenberg D, Ward MG, Leong RW; IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1037-1053. doi: 10.1111/apt.14368. Epub 2017 Oct 13. Review.

37.

Accurate Assignments of Excited-State Resonance Raman Spectra: A Benchmark Study Combining Experiment and Theory.

Barclay MS, Quincy TJ, Williams-Young DB, Caricato M, Elles CG.

J Phys Chem A. 2017 Oct 19;121(41):7937-7946. doi: 10.1021/acs.jpca.7b09467. Epub 2017 Oct 6.

PMID:
28953391
38.

Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study.

Stamp LK, Chapman PT, Barclay M, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Ann Rheum Dis. 2017 Dec;76(12):2065-2070. doi: 10.1136/annrheumdis-2017-211873. Epub 2017 Aug 22.

PMID:
28830881
39.

Cancer-Related Fatigue in Adolescents and Young Adults After Cancer Treatment: Persistent and Poorly Managed.

Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, Barclay M, Brimicombe J, Thiemann P, McCabe MG, Campsey R, Hooker L, Moss W, Robson J, Barclay S.

J Adolesc Young Adult Oncol. 2017 Sep;6(3):489-493. doi: 10.1089/jayao.2017.0037. Epub 2017 Jul 17.

40.

Deterministic identifiability of population pharmacokinetic and pharmacokinetic-pharmacodynamic models.

Siripuram VK, Wright DFB, Barclay ML, Duffull SB.

J Pharmacokinet Pharmacodyn. 2017 Oct;44(5):415-423. doi: 10.1007/s10928-017-9530-4. Epub 2017 Jun 13.

PMID:
28612141
41.

Between "the best way to deliver patient care" and "chaos and low clinical value": General Practitioners' and Practice Managers' views on data sharing.

Petrova M, Barclay M, Barclay SS, Barclay SIG.

Int J Med Inform. 2017 Aug;104:74-83. doi: 10.1016/j.ijmedinf.2017.05.009. Epub 2017 May 17.

PMID:
28599819
42.

Protein degradation rate is the dominant mechanism accounting for the differences in protein abundance of basal p53 in a human breast and colorectal cancer cell line.

Lakatos E, Salehi-Reyhani A, Barclay M, Stumpf MPH, Klug DR.

PLoS One. 2017 May 10;12(5):e0177336. doi: 10.1371/journal.pone.0177336. eCollection 2017.

43.

Individualising the dose of allopurinol in patients with gout.

Kannangara DRW, Graham GG, Wright DFB, Stocker SL, Portek I, Pile KD, Barclay ML, Williams KM, Stamp LK, Day RO.

Br J Clin Pharmacol. 2017 Sep;83(9):2015-2026. doi: 10.1111/bcp.13307. Epub 2017 May 28.

44.

Oxygen-promoted catalyst sintering influences number density, alignment, and wall number of vertically aligned carbon nanotubes.

Shi W, Li J, Polsen ES, Oliver CR, Zhao Y, Meshot ER, Barclay M, Fairbrother DH, Hart AJ, Plata DL.

Nanoscale. 2017 Apr 20;9(16):5222-5233. doi: 10.1039/c6nr09802a.

PMID:
28397885
45.

Preferences for care towards the end of life when decision-making capacity may be impaired: A large scale cross-sectional survey of public attitudes in Great Britain and the United States.

Clarke G, Fistein E, Holland A, Barclay M, Theimann P, Barclay S.

PLoS One. 2017 Apr 5;12(4):e0172104. doi: 10.1371/journal.pone.0172104. eCollection 2017.

46.

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout.

Stamp LK, Chapman PT, Barclay ML, Horne A, Frampton C, Tan P, Drake J, Dalbeth N.

Ann Rheum Dis. 2017 Sep;76(9):1522-1528. doi: 10.1136/annrheumdis-2016-210872. Epub 2017 Mar 17.

PMID:
28314755
47.

Presenteeism in the New Zealand senior medical workforce-a mixed-methods analysis.

Chambers C, Frampton C, Barclay M.

N Z Med J. 2017 Jan 27;130(1449):10-21.

PMID:
28178725
48.

Comment on: "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study".

Kamel KS, Chin PK, Doogue MP, Barclay ML.

Clin Pharmacokinet. 2017 Feb;56(2):207-208. doi: 10.1007/s40262-016-0481-5. No abstract available.

PMID:
28035591
49.

Adenosine receptors regulate susceptibility to noise-induced neural injury in the mouse cochlea and hearing loss.

Vlajkovic SM, Ambepitiya K, Barclay M, Boison D, Housley GD, Thorne PR.

Hear Res. 2017 Mar;345:43-51. doi: 10.1016/j.heares.2016.12.015. Epub 2016 Dec 26.

PMID:
28034618
50.

Supplemental Content

Loading ...
Support Center